Treatment of digestive tract infections caused by bacteria sensitive to rifaximin, including: – acute gastrointestinal infections;
-
travelers’diarrhea;
-
syndrome of excessive growth of microorganisms in the intestine; – with hepatic encephalopathy;
-
with symptomatic uncomplicated diverticular disease of the colon;
-
with chronic intestinal inflammation.





